EMEA (Europe, Middle East and Africa) Nuclear Medicine & Radio Pharmaceuticals Market Report 2017

  • ID:PD005172
  • May 2017
  • QY Research
                          

The EMEA (Europe, Middle East and Africa) Nuclear Medicine & Radio Pharmaceuticals Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure, consumption value and sale price. The key companies of the EMEA (Europe, Middle East and Africa) Nuclear Medicine & Radio Pharmaceuticals market, manufacturers, distributors along with the latest development trends and Forecasts are detailed in the Report.

In this report, the EMEA Nuclear Medicine & Radio Pharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals for these regions, from 2012 to 2022 (forecast)

  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Nuclear Medicine & Radio Pharmaceuticals market competition by top manufacturers/players, with Nuclear Medicine & Radio Pharmaceuticals sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthcare
  • Toshiba
  • Hitachi
  • Carestream
  • Esaote
  • Shimadzu
  • TriFoil Imaging
  • Biosensors International Group, Ltd

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
  • Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals for each application, including
Diagnostic Applications: SPECT, PET.
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

Table of Contents – Snapshot
1 Overview
2 EMEA Competition by Manufacturers/Players/Suppliers, Region, Type and Application
3 Europe (Volume, Value and Sales Price), by Players, Countries, Type and Application
4 Middle East (Volume, Value and Sales Price), by Region, Type and Application
5 Africa (Volume, Value and Sales Price) by Players, Countries, Type and Application
6 EMEA Manufacturers/Players Profiles and Sales Data
7 Manufacturing Cost Analysis
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
10 Market Effect Factors Analysis
11 EMEA Market Forecast (2017-2022)
12 Research Findings and Conclusion
13 Appendix

Table of Contents - Guidelines
 
EMEA (Europe, Middle East and Africa) Nuclear Medicine & Radio Pharmaceuticals Market Report 2017
1 Nuclear Medicine & Radio Pharmaceuticals Overview
1.1 Product Overview and Scope
1.2 Classification
1.2.1 EMEA Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
1.2.4 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
1.3 EMEA Nuclear Medicine & Radio Pharmaceuticals Market by Application/End Users
1.3.1 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Diagnostic Applications: SPECT, PET.
1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.4 EMEA Nuclear Medicine & Radio Pharmaceuticals Market by Region
1.4.1 EMEA Nuclear Medicine & Radio Pharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume)  (2012-2022)
1.5.1 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2022)
1.5.2 EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2022)
 
2 EMEA Nuclear Medicine & Radio Pharmaceuticals Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Nuclear Medicine & Radio Pharmaceuticals Market Competition by Players/Manufacturers
2.1.1 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue and Share by Players (2012-2017)
2.1.3 EMEA Nuclear Medicine & Radio Pharmaceuticals Sale Price by Players (2012-2017)
2.2 EMEA Nuclear Medicine & Radio Pharmaceuticals (Volume and Value) by Type/Product Category
2.2.1 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Nuclear Medicine & Radio Pharmaceuticals Sale Price by Type (2012-2017)
2.3 EMEA Nuclear Medicine & Radio Pharmaceuticals (Volume) by Application
2.4 EMEA Nuclear Medicine & Radio Pharmaceuticals (Volume and Value) by Region
2.4.1 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Price by Region (2012-2017)
 
3 Europe Nuclear Medicine & Radio Pharmaceuticals (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales and Value (2012-2017)
3.1.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
3.2 Europe Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type
3.3 Europe Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Application
3.4 Europe Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales Volume by Countries (2012-2017)
3.4.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2012-2017)
3.4.3 Germany Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
3.4.4 France Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
3.4.5 UK Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
3.4.6 Russia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
3.4.7 Italy Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
3.4.8 Benelux Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
 
4 Middle East Nuclear Medicine & Radio Pharmaceuticals (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Nuclear Medicine & Radio Pharmaceuticals Sales and Value (2012-2017)
4.1.1 Middle East Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
4.2 Middle East Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type
4.3 Middle East Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Application
4.4 Middle East Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Nuclear Medicine & Radio Pharmaceuticals Sales Volume by Countries (2012-2017)
4.4.2 Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
4.4.4 Israel Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
4.4.5 UAE Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
4.4.6 Iran Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
 
5 Africa Nuclear Medicine & Radio Pharmaceuticals (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Value (2012-2017)
5.1.1 Africa Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
5.2 Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type
5.3 Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Application
5.4 Africa Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Nuclear Medicine & Radio Pharmaceuticals Sales Volume by Countries (2012-2017)
5.4.2 Africa Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2012-2017)
5.4.3 South Africa Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
5.4.5 Egypt Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
5.4.6 Algeria Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2017)
 
6 EMEA Nuclear Medicine & Radio Pharmaceuticals Manufacturers/Players Profiles and Sales Data
6.1 GE Healthcare
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Philips Healthcare
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Siemens Healthcare
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Toshiba
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Hitachi
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Carestream
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Esaote
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Shimadzu
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 TriFoil Imaging
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Biosensors International Group, Ltd
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
 
7 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Cost Analysis
7.1 Nuclear Medicine & Radio Pharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis
 
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources  Major Manufacturers in 2016
8.4 Downstream Buyers
 
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
 
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
 
11 EMEA Nuclear Medicine & Radio Pharmaceuticals Market Forecast (2017-2022)
11.1 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Nuclear Medicine & Radio Pharmaceuticals Price and Trend Forecast (2017-2022)
11.2 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Type (2017-2022)
11.7 EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Application (2017-2022)
 
12 Research Findings and Conclusion
 
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
 
Figure Product Picture of Nuclear Medicine & Radio Pharmaceuticals
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Product Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Product Picture
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Application in 2016
Figure Diagnostic Applications: SPECT, PET. Examples
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Volume and Growth Rate (2012-2022)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players (2012-2017)
Figure 2016 Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players
Figure 2017 Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Players (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players (2012-2017)
Table 2016 EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players
Table 2017 EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2012-2017)
Figure Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type (2012-2017)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type in 2016
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Share by Application (2012-2017)
Figure Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Application (2012-2017)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application in 2016
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Share by Region (2012-2017)
Figure Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Region (2012-2017)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in 2016
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Region (2012-2017)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share Regions in 2016
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2017)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Type (2012-2017)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Market Share by Type (2012-2017)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Share by Type in 2016
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Application (2012-2017)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Market Share by Application (2012-2017)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Share by Application in 2016
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Countries (2012-2017)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries in 2016
Table Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries in 2016
Figure Germany Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure France Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure UK Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Type (2012-2017)
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Market Share by Type (2012-2017)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Market Share by Type (2012-2017)
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Applications (2012-2017)
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Market Share by Applications (2012-2017)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application in 2016
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Countries in 2016
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries in 2016
Figure Saudi Arabia Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Type (2012-2017)
Table Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type in 2016
Table Africa Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Application (2012-2017)
Table Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2012-2017)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2012-2017)
Table Africa Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) by Countries (2012-2017)
Table Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries in 2016
Table Africa Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries in 2016
Figure South Africa Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Basic Information List
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine & Radio Pharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016
Table Major Buyers of Nuclear Medicine & Radio Pharmaceuticals
Table Distributors/Traders List
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Market Share Forecast by Region (2017-2022)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share Forecast by Region (2017-2022)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Africa Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Market Share Forecast by Type (2017-2022)
Table EMEA Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Nuclear Medicine & Radio Pharmaceuticals Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..